PubMed HealthSearch

PubMed · 8648285

Test question modulates cue competition between causes and between effects.

Abstract

The research reported in this article replicated the well-established phenomenon of competition between causes (C) as well as the more controversial presence and absence of competition between effects (E). The test question was identified as a crucial factor leading to each outcome. Competition between causes was obtained when the test question asked about the probability of E given C, p(E/C), implicitly compared with the probability of E given some alternative cause, p(E/C'). competition between effects was obtained when the test question asked about p(C/E) implicitly compared with p(C/E'). Under these conditions, effects competed for diagnostic value just as causes competed for predictive value. Additionally, some conditions in which neither causes nor effects competed were identified. These results suggest a bidirectional and noncompetitive learning process, the contents of which can be used in different ways (competitively or noncompetitively and forward or backward) as a function of test demands.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Matute, F Arcediano, R R Miller. 1996. Test question modulates cue competition between causes and between effects.. https://doi.org/10.1037/%2F0278-7393.22.1.182

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The causal relationship between multiple cardiovascular diseases and glioblastoma: A Mendelian randomization study.

Observational studies suggest an association between glioblastoma (GBM) and cardiovascular diseases (CVDs), but a causal relationship remains unestablished. This study aimed to investigate the causal link between multiple CVDs and GBM risk. The inverse variance weighted method indicated that all 18 CVDs had significant causal associations with GBM (P&#x2005;<&#x2005;.05). Genetically predicted CVDs were uniformly associated with a lower risk of GBM (odds ratio&#x2005;<&#x2005;1), identifying them as potential protective factors. Sensitivity analyses confirmed the absence of significant heterogeneity or horizontal pleiotropy, and the MR-Steiger test validated the correct causal direction. This Mendelian randomization (MR) study provides evidence that a range of CVDs are causally associated with a decreased risk of developing GBM. These findings suggest shared biological pathways and offer new insights for understanding GBM etiology. We conducted a 2-sample MR analysis using publicly available genome-wide association study data. GBM was the outcome, and 18 cardiovascular-related traits (including coronary artery disease, myocardial infarction, and venous thromboembolism) were exposures. Instrumental variables were single-nucleotide polymorphisms significantly associated with exposures (P&#x2005;<&#x2005;5&#x2005;&#xd7;&#x2005;10-8). The primary analysis used the inverse variance weighted method, supplemented with MR-Egger, weighted median, and weighted mode methods. Sensitivity analyses, including Cochran Q test, MR-Egger intercept test, leave-one-out analysis, and MR-Steiger directionality test, were performed to ensure robustness.

Causality